Document Detail

What Agent Should be Used to Prevent Recurrent Preterm Birth: 17-P or Natural Progesterone?
MedLine Citation:
PMID:  21575799     Owner:  NLM     Status:  In-Data-Review    
Preterm birth has increased over the last decade. In 2006, 12.5% of all births in the United States occurred at fewer than 37 weeks gestation. This is associated with significant health care costs as well as related neonatal morbidity and mortality. In 2003, costs related to care for infants with preterm-birth or low-birth weight exceeded 11 billion dollars. This article reviews the literature on 17 alpha-hydroxyprogesterone caproate (17-P) and natural progesterone and concludes that 17-P is indicated for prevention of preterm birth in women with a documented history of a preterm birth before 37 weeks.
Nicole Ruddock Hall
Related Documents :
16510629 - Dietary energy intake at the age of 4 months predicts postnatal weight gain and childho...
19115369 - Attitudes toward weight gain during pregnancy: results from the norwegian mother and ch...
7335549 - Lipomatosis of the pancreas. a morphometrical investigation.
15843259 - Characteristics of mothers who delivered the heaviest, average-weight, and lightest tri...
1186189 - Weight control for high school wrestlers.
25012139 - Historic records on the commercial production of infant formula.
22745059 - Endo-β-n-acetylglucosaminidases from infant gut-associated bifidobacteria release comp...
24030199 - Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocol...
2314939 - Periodic breathing and apnea in preterm infants.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology clinics of North America     Volume:  38     ISSN:  1558-0474     ISO Abbreviation:  Obstet. Gynecol. Clin. North Am.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8709551     Medline TA:  Obstet Gynecol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  235-46     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Division of Maternal Fetal Medicine, Department of Obstetrics/Gynecology, University of Texas Health Science Center, 5656 Kelley Street, Houston, TX 77026, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Oral hypoglycemic agents in pregnancy.
Next Document:  Reducing the Risk of Shoulder Dystocia and Associated Brachial Plexus Injury.